ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronEye IconIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintSite TitleTitle ChevronIcon Twitter
Coronavirus

Japan's Takara Bio cuts coronavirus test time in half

Asia’s largest research reagent company supplies enough to test 2 million per month

Takara Bio has developed a new reagent which allows coronavirus infections to be determined in about an hour.   © Takara Bio

TOKYO -- Japanese biotech company Takara Bio said Thursday it has developed a new reagent which allows coronavirus infections to be determined in about an hour, slashing the required testing time by more than half from existing methods. 

The newly developed substance, which goes on sale Friday, eliminates the need to remove impurities from samples. It normally takes two or three hours to complete polymerase chain reaction, or PCR, based tests. 

The company will supply reagent sufficient to test 2 million specimens per month. 

The product, manufactured at a facility based in the northeastern Chinese city of Dalian, will be sold for 120,000 yen ($1,125), enough for 100 test specimens. Samples taken from the throat or nose contain impurities that slow down the testing process, but the new substance is unaffected by them.

As Asia’s largest research reagent developer, Takara Bio has been working on increasing production of PCR reagents. Similar moves are being taken by Shimadzu and other companies.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

Stay ahead with our exclusives on Asia;
the most dynamic market in the world.

Stay ahead with our exclusives on Asia

Get trusted insights from experts within Asia itself.

Get trusted insights from experts
within Asia itself.

Get Unlimited access

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

This is your last free article this month

Stay ahead with our exclusives on Asia; the most
dynamic market in the world
.

Get trusted insights from experts
within Asia itself.

Try 3 months for $9

Offer ends April 30th

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to the Nikkei Asian Review has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media